Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06RPY
|
||||
Former ID |
DNC004853
|
||||
Drug Name |
2-[4-(1-Ethyl-propyl)-piperazin-1-yl]-quinoline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527370] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H25N3
|
||||
Canonical SMILES |
CCC(CC)N1CCN(CC1)C2=NC3=CC=CC=C3C=C2
|
||||
InChI |
1S/C18H25N3/c1-3-16(4-2)20-11-13-21(14-12-20)18-10-9-15-7-5-6-8-17(15)19-18/h5-10,16H,3-4,11-14H2,1-2H3
|
||||
InChIKey |
FNSKLNDKQPXTIL-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Histamine H3 receptor | Target Info | Inhibitor | [527370] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.